In the context of rising healthcare costs and an aging population, this systematic review brings to light the challenges primary care providers face in efficiently identifying adverse drug reactions (ADRs) in the elderly who are on multiple medications. It emphasizes the need for strategic, cost-effective methods to monitor ADRs without imposing additional financial burdens on the healthcare system. The review advocates for the use of innovative, market-driven solutions to enhance patient safety while ensuring that resources are allocated in a manner that supports sustainability and economic growth.
Systematic Review Calls for Cost-Effective Strategies in Monitoring Drug Reactions in Older Adults
All Versions
Feb-05
Health
Score: 0.50
Background Identification of real-time adverse drug reactions [ADRs] (as opposed to the risk of ADRs) in older poly-medicated people in primary care is a challenging task, often undertaken without an explicit strategy. This systematic review aims to evaluate …
From Plos.org
Feb-05
Health
Left Variant
Score: 0.20
Against the backdrop of rising pharmaceutical interventions in underserved populations, this systematic review underscores a critical public health issue—the inadequate identification of adverse drug reactions (ADRs) among elderly, poly-medicated individuals in primary care settings. The study reveals a glaring gap in the proactive and real-time monitoring of ADRs, a problem exacerbated by the lack of comprehensive strategies tailored to the needs of these communities. It highlights the necessity of integrating equity-focused policies and community-based approaches to safeguard the health of marginalized groups, advocating for a healthcare system that prioritizes the well-being of all its members.
From Plos.org